On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
Clinical trial NCT02376478 · COMPLETED
Trial details
- NCT number
- NCT02376478
- Sponsor
- Medical University of Vienna
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-01-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.